Timothy Culberson filed a motion in the US Bankruptcy Court seeking the dismissal of Sorrento Therapeutics, Inc.'s Chapter 11 bankruptcy case on February 9, 2024. This motion to dismiss or transfer venue is needed because fraud and factual misrepresentations were recently uncovered and confirmed through documented evidence.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.012 USD | -7.69% | -14.29% | -90.28% |
Apr. 10 | Sorrento Therapeutics, Inc. Emerged from Bankruptcy | CI |
Mar. 15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
1st Jan change | Capi. | |
---|---|---|
-90.28% | 6.52M | |
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- SRNE Stock
- News Sorrento Therapeutics, Inc.
- Motion for Case Dismissal Filed for Sorrento Therapeutics, Inc.